Dudek AZ, Liu LC, Fischer JH, Wiley EL, et al. Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy. Breast Cancer Res Treat 2020 Jul 22. pii: 10.1007/s10549-020-05787.
PMID: 32696319